【表紙】

 

【提出書類】

有価証券報告書

【根拠条文】

金融商品取引法第24条第1項

【提出先】

関東財務局長

【提出日】

2024年6月25日

【事業年度】

第23期(自 2023年4月1日 至 2024年3月31日)

【会社名】

オンコセラピー・サイエンス株式会社

【英訳名】

OncoTherapy Science, Inc.

【代表者の役職氏名】

代表取締役社長  嶋田 順一

【本店の所在の場所】

神奈川県川崎市川崎区東田町1番地2

【電話番号】

044-201-6429

【事務連絡者氏名】

管理本部統括取締役  朴 在賢

【最寄りの連絡場所】

神奈川県川崎市川崎区東田町1番地2

【電話番号】

044-201-6429

【事務連絡者氏名】

管理本部統括取締役  朴 在賢

【縦覧に供する場所】

株式会社東京証券取引所

(東京都中央区日本橋兜町2番1号)

 

E05363 45640 オンコセラピー・サイエンス株式会社 OncoTherapy Science, Inc. 企業内容等の開示に関する内閣府令 第三号様式 Japan GAAP true CTE CTE 2023-04-01 2024-03-31 FY 2024-03-31 2022-04-01 2023-03-31 2023-03-31 1 false false false E05363-000 2024-03-31 jppfs_cor:TreasuryStockMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:TreasuryStockMember E05363-000 2023-03-31 jppfs_cor:TreasuryStockMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:TreasuryStockMember E05363-000 2022-03-31 jppfs_cor:TreasuryStockMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:OtherCapitalSurplusMember E05363-000 2024-03-31 jppfs_cor:LegalCapitalSurplusMember jppfs_cor:NonConsolidatedMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalStockMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:SubscriptionRightsToSharesMember E05363-000 2022-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsBroughtForwardMember E05363-000 2024-03-31 E05363-000 2023-04-01 2024-03-31 E05363-000 2023-03-31 E05363-000 2022-04-01 2023-03-31 E05363-000 2022-03-31 E05363-000 2021-04-01 2022-03-31 E05363-000 2021-03-31 E05363-000 2020-04-01 2021-03-31 E05363-000 2024-06-25 E05363-000 2020-03-31 E05363-000 2019-04-01 2020-03-31 E05363-000 2022-04-01 2023-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember E05363-000 2024-06-25 jpcrp030000-asr_E05363-000:ShimadaJunichiMember E05363-000 2024-06-25 jpcrp030000-asr_E05363-000:MikiYoshioMember E05363-000 2024-03-31 jpcrp_cor:No7MajorShareholdersMember E05363-000 2024-06-25 jpcrp030000-asr_E05363-000:KatoHatsuoMember E05363-000 2024-03-31 jpcrp_cor:SharesWithNoVotingRightsMember E05363-000 2023-04-01 2024-03-31 jpcrp_cor:ReconcilingItemsMember E05363-000 2023-04-01 2024-03-31 jpcrp_cor:ReportableSegmentsMember E05363-000 2023-04-01 2024-03-31 jpcrp030000-asr_E05363-000:CancerPrecisionMedicalBusinessReportableSegmentsMember E05363-000 2023-04-01 2024-03-31 jpcrp030000-asr_E05363-000:ResearchAndDevelopmentOfPharmaceuticalProductsReportableSegmentsMember E05363-000 2023-03-31 jppfs_cor:CapitalSurplusMember E05363-000 2023-03-31 jppfs_cor:CapitalStockMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:SubscriptionRightsToSharesMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:CapitalSurplusMember E05363-000 2023-03-31 jpcrp030000-asr_E05363-000:CancerPrecisionMedicalBusinessReportableSegmentsMember E05363-000 2022-04-01 2023-03-31 jpcrp030000-asr_E05363-000:CancerPrecisionMedicalBusinessReportableSegmentsMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2023-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2022-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2020-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:SubscriptionRightsToSharesMember E05363-000 2024-03-31 jppfs_cor:SubscriptionRightsToSharesMember E05363-000 2024-03-31 jppfs_cor:ShareholdersEquityMember E05363-000 2024-03-31 jppfs_cor:RetainedEarningsMember E05363-000 2024-03-31 jppfs_cor:CapitalSurplusMember E05363-000 2024-03-31 jppfs_cor:CapitalStockMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:SubscriptionRightsToSharesMember E05363-000 2024-06-25 jpcrp030000-asr_E05363-000:YamaneYukaMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:ShareholdersEquityMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:RetainedEarningsMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:CapitalSurplusMember E05363-000 2020-04-01 2021-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2024-03-31 jpcrp_cor:SharesWithRestrictedVotingRightsTreasurySharesEtcMember E05363-000 2024-03-31 jpcrp_cor:SharesWithRestrictedVotingRightsOtherMember E05363-000 2024-03-31 jpcrp_cor:SharesWithFullVotingRightsTreasurySharesEtcMember E05363-000 2024-03-31 jpcrp_cor:SharesWithFullVotingRightsOtherMember E05363-000 2024-03-31 jpcrp_cor:OrdinarySharesSharesWithFullVotingRightsOtherMember E05363-000 2023-04-01 2024-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember E05363-000 2023-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ShareholdersEquityMember E05363-000 2023-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsMember E05363-000 2024-03-31 jpcrp_cor:Row1Member E05363-000 2024-06-25 jpcrp030000-asr_E05363-000:JAEHYUNPARKMember E05363-000 2022-03-31 jppfs_cor:ShareholdersEquityMember E05363-000 2022-03-31 jppfs_cor:CapitalStockMember jppfs_cor:NonConsolidatedMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:RetainedEarningsBroughtForwardMember jppfs_cor:NonConsolidatedMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:CapitalSurplusMember jppfs_cor:NonConsolidatedMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:OtherCapitalSurplusMember jppfs_cor:NonConsolidatedMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:CapitalStockMember jppfs_cor:NonConsolidatedMember E05363-000 2022-03-31 jppfs_cor:SubscriptionRightsToSharesMember jppfs_cor:NonConsolidatedMember E05363-000 2022-03-31 jppfs_cor:ShareholdersEquityMember jppfs_cor:NonConsolidatedMember E05363-000 2022-03-31 jppfs_cor:RetainedEarningsMember jppfs_cor:NonConsolidatedMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:RetainedEarningsBroughtForwardMember jppfs_cor:NonConsolidatedMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:CapitalSurplusMember jppfs_cor:NonConsolidatedMember E05363-000 2024-06-25 jpcrp030000-asr_E05363-000:KomineYuichiMember E05363-000 2024-06-25 jpcrp030000-asr_E05363-000:TakagiMiyakoMember E05363-000 2024-06-25 jpcrp030000-asr_E05363-000:TajimaTeruhisaMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:OtherCapitalSurplusMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalStockMember E05363-000 2023-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:SubscriptionRightsToSharesMember E05363-000 2023-03-31 jpcrp030000-asr_E05363-000:ResearchAndDevelopmentOfPharmaceuticalProductsReportableSegmentsMember E05363-000 2023-03-31 jpcrp_cor:ReconcilingItemsMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E05363-000:ResearchAndDevelopmentOfPharmaceuticalProductsReportableSegmentsMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E05363-000:CancerPrecisionMedicalBusinessReportableSegmentsMember E05363-000 2023-04-01 2024-03-31 jpcrp_cor:CorporateAuditorsExcludingOutsideCorporateAuditorsMember E05363-000 2023-04-01 2024-03-31 jpcrp_cor:OutsideDirectorsAndOtherOfficersMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:ReserveForReductionEntry1Member jppfs_cor:NonConsolidatedMember E05363-000 2022-03-31 jppfs_cor:ReserveForReductionEntry1Member jppfs_cor:NonConsolidatedMember E05363-000 2023-03-31 jppfs_cor:SubscriptionRightsToSharesMember E05363-000 2023-03-31 jppfs_cor:ShareholdersEquityMember E05363-000 2023-03-31 jppfs_cor:RetainedEarningsMember E05363-000 2024-06-25 jpcrp_cor:Row5Member E05363-000 2022-03-31 jppfs_cor:RetainedEarningsMember E05363-000 2022-03-31 jppfs_cor:CapitalSurplusMember E05363-000 2022-03-31 jppfs_cor:CapitalStockMember E05363-000 2023-03-31 jppfs_cor:CapitalStockMember jppfs_cor:NonConsolidatedMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:SubscriptionRightsToSharesMember jppfs_cor:NonConsolidatedMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:ShareholdersEquityMember jppfs_cor:NonConsolidatedMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:CapitalStockMember E05363-000 2022-03-31 jppfs_cor:SubscriptionRightsToSharesMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:ShareholdersEquityMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:RetainedEarningsMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2024-03-31 jppfs_cor:RetainedEarningsMember jppfs_cor:NonConsolidatedMember E05363-000 2024-03-31 jppfs_cor:RetainedEarningsBroughtForwardMember jppfs_cor:NonConsolidatedMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ReserveForReductionEntry1Member E05363-000 2023-03-31 jppfs_cor:CapitalSurplusMember jppfs_cor:NonConsolidatedMember E05363-000 2023-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:OtherCapitalSurplusMember E05363-000 2023-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E05363-000 2024-03-31 jpcrp_cor:No10MajorShareholdersMember E05363-000 2024-03-31 jpcrp_cor:No9MajorShareholdersMember E05363-000 2024-03-31 jpcrp_cor:No8MajorShareholdersMember E05363-000 2023-04-01 2024-03-31 jpcrp_cor:DirectorsExcludingOutsideDirectorsMember E05363-000 2024-03-31 jpcrp030000-asr_E05363-000:ResearchAndDevelopmentOfPharmaceuticalProductsReportableSegmentsMember E05363-000 2023-03-31 jpcrp_cor:ReportableSegmentsMember E05363-000 2022-04-01 2023-03-31 jpcrp_cor:ReportableSegmentsMember E05363-000 2024-03-31 jpcrp_cor:ReconcilingItemsMember E05363-000 2024-03-31 jpcrp_cor:ReportableSegmentsMember E05363-000 2024-03-31 jpcrp030000-asr_E05363-000:CancerPrecisionMedicalBusinessReportableSegmentsMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:ShareholdersEquityMember jppfs_cor:NonConsolidatedMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:RetainedEarningsMember jppfs_cor:NonConsolidatedMember E05363-000 2024-06-25 jpcrp_cor:Row3Member E05363-000 2024-06-25 jpcrp_cor:Row2Member E05363-000 2023-04-01 2024-03-31 jppfs_cor:ReserveForReductionEntry1Member jppfs_cor:NonConsolidatedMember E05363-000 2023-03-31 jppfs_cor:ReserveForReductionEntry1Member jppfs_cor:NonConsolidatedMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ShareholdersEquityMember E05363-000 2024-06-25 jpcrp_cor:OrdinaryShareMember E05363-000 2024-03-31 jpcrp_cor:OrdinaryShareMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalSurplusMember E05363-000 2024-06-25 jpcrp_cor:Row1Member E05363-000 2024-06-25 jpcrp_cor:Row4Member E05363-000 2023-04-01 2024-03-31 jppfs_cor:CapitalStockMember E05363-000 2023-03-31 jppfs_cor:RetainedEarningsBroughtForwardMember jppfs_cor:NonConsolidatedMember E05363-000 2024-03-31 jpcrp_cor:SharesLessThanOneUnitMember E05363-000 2024-03-31 jpcrp_cor:OrdinarySharesSharesLessThanOneUnitMember E05363-000 2019-04-01 2020-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2024-03-31 jpcrp_cor:No6MajorShareholdersMember E05363-000 2024-03-31 jpcrp_cor:No5MajorShareholdersMember E05363-000 2024-03-31 jpcrp_cor:No4MajorShareholdersMember E05363-000 2024-03-31 jpcrp_cor:No3MajorShareholdersMember E05363-000 2024-03-31 jpcrp_cor:No2MajorShareholdersMember E05363-000 2024-03-31 jpcrp_cor:No1MajorShareholdersMember E05363-000 2021-04-01 2022-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2021-03-31 jppfs_cor:NonConsolidatedMember E05363-000 2022-03-31 jppfs_cor:CapitalSurplusMember jppfs_cor:NonConsolidatedMember E05363-000 2022-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:OtherCapitalSurplusMember E05363-000 2022-03-31 jppfs_cor:LegalCapitalSurplusMember jppfs_cor:NonConsolidatedMember E05363-000 2022-04-01 2023-03-31 jpcrp030000-asr_E05363-000:ResearchAndDevelopmentOfPharmaceuticalProductsReportableSegmentsMember E05363-000 2022-04-01 2023-03-31 jpcrp_cor:ReconcilingItemsMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsMember E05363-000 2023-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:TreasuryStockMember E05363-000 2023-04-01 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:TreasuryStockMember E05363-000 2024-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:TreasuryStockMember E05363-000 2022-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:TreasuryStockMember E05363-000 2022-04-01 2023-03-31 jppfs_cor:NonConsolidatedMember jppfs_cor:TreasuryStockMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:shares xbrli:pure